missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TCR V alpha 2 Monoclonal Antibody (B20.1), NovaFluor™ Red 700, eBioscience™, Invitrogen™
Rat Monoclonal Antibody
Brand: Invitrogen™ M033T02R03-A
This item is not returnable.
View return policy
Description
The ability of T cell receptors (TCR) to discriminate foreign from self-peptides presented by major histocompatibility complex (MHC) class II molecules is essential for an effective adaptive immune response. TCR recognition of self-peptides has been linked to autoimmune disease. Mutant self-peptides have been associated with tumors. Engagement of TCRs by a family of bacterial toxins know as superantigens has been responsible for toxic shock syndrome. Autoantibodies to V beta segments of T cell receptors have been isolated from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The autoantibodies block TH1-mediated inflammatory autodestructive reactions and are believed to be a method by which the immune system compensates for disease. Most human T cells express the TCR alpha-beta and either CD4 or CD8 molecule (single positive, SP). A small number of T cells lack both CD4 and CD8 (double negative, DN). Increased percentages of alpha-beta DN T cells have been identified in some autoimmune and immunodeficiency disorders. Gamma-delta T cells are primarily found within the epithelium. They show less TCR diversity and recognize antigens differently than alpha-beta T cells. Subsets of gamma-delta T cells have shown antitumor and immunoregulatory activity.
Specifications
| TCR V alpha 2 | |
| Monoclonal | |
| 0.1 mg/mL | |
| PBS with 0.09% sodium azide; pH 7.2 | |
| Rat | |
| 25 μg | |
| Primary | |
| 4°C, store in dark, DO NOT FREEZE! | |
| Liquid | |
| IgG2a λ |
| Flow Cytometry | |
| B20.1 | |
| NovaFluor Red 700 | |
| TCRVA; TCRVA2; V alpha 2; V alpha-2 TCR; Va 2; Va2; Valpha 2; Valpha2 | |
| Affinity chromatography | |
| RUO | |
| Mouse | |
| Antibody | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction